Gilead Sciences, Inc.

Gilead Sciences, Inc. - PE Ratioverified

GILD

Price:

$123.76

Market Cap:

$153.66B

Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vo...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1992-01-22

Stock Exchange

NASDAQ

Ticker

GILD

The PE Ratio as of June 2026 (TTM) for Gilead Sciences, Inc. (GILD) is 14.79

According to Gilead Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 14.79. This represents a change of -12.67% compared to the average of 16.94 of the last 4 quarters.

Gilead Sciences, Inc. (GILD) Historical PE Ratio (quarterly & annually)

How has GILD PE Ratio performed in the past?

The mean historical PE Ratio of Gilead Sciences, Inc. over the last ten years is 96.96. The current 14.79 PE Ratio has changed 1.43% with respect to the historical average. Over the past ten years (40 quarters), GILD's PE Ratio was at its highest in in the December 2018 quarter at 6.80K. The PE Ratio was at its lowest in in the September 2019 quarter at -17.22.

Quarterly (TTM)
Annual

Average

96.96

Median

17.89

Minimum

7.10

Maximum

595.10

Gilead Sciences, Inc. (GILD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Gilead Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.78%

Maximum Annual PE Ratio = 595.10

Minimum Annual Increase = -97.54%

Minimum Annual PE Ratio = 7.10

Quarterly (TTM)
Annual
YearPE RatioChange
202517.94-92.62%
2024243.081.26%
202317.84-23.93%
202223.4660.23%
202114.64-97.54%
2020595.103.78%
201915.332.90%
201814.89-26.41%
201720.24184.87%
20167.10-13.15%

Gilead Sciences, Inc. (GILD) Average PE Ratio

How has GILD PE Ratio performed in the past?

The current PE Ratio of Gilead Sciences, Inc. (GILD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

92.96

5-year avg

63.39

10-year avg

96.96

Gilead Sciences, Inc. (GILD) PE Ratio vs. Peers

How is GILD’s PE Ratio compared to its peers?

Gilead Sciences, Inc.’s PE Ratio is less than Pfizer Inc. (19.25), less than Amgen Inc. (23.31), greater than Sanofi (11.75), less than Bristol-Myers Squibb Company (15.17), greater than GSK plc (13.28), less than Merck & Co., Inc. (31.99), less than Danaher Corporation (34.14), less than Boston Scientific Corporation (18.87), greater than Novo Nordisk A/S (10.68), less than Stryker Corporation (35.26),

CompanyPE RatioMarket cap
19.25$143.74B
23.31$182.21B
11.75$101.89B
15.17$110.27B
13.28$101.54B
31.99$281.24B
34.14$125.40B
18.87$67.32B
10.68$191.93B
35.26$118.00B

Build a custom stock screener for Gilead Sciences, Inc. (GILD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gilead Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gilead Sciences, Inc. (GILD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gilead Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Gilead Sciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Gilead Sciences, Inc. (GILD)?

What is the highest PE Ratio for Gilead Sciences, Inc. (GILD)?

What is the 3-year average PE Ratio for Gilead Sciences, Inc. (GILD)?

What is the 5-year average PE Ratio for Gilead Sciences, Inc. (GILD)?

How does the current PE Ratio for Gilead Sciences, Inc. (GILD) compare to its historical average?